12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MDCO-2010: Development discontinued

Medicines Co. discontinued MDCO-2010 after seeing "serious" safety issues in a Phase IIb trial of the compound to reduce blood loss during surgery. Medicines Co. declined to disclose details of the issues, but...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >